| Description | Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes. |
| Synonyms | SP 2086, 瑞格列汀磷酸盐 |
| molecular weight | 562.36 |
| Molecular formula | C19H21F6N4O7P |
| CAS | 1256756-88-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: ≥ 150 mg/mL (266.73 mM) |
| References | 1. Hu C, et al. Pharmacokinetics of Phosphate Retagliptin Tabletin in Patients with Renal Dysfunction. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Jan;49(1):74-80. |